✦ LIBER ✦

313 A 1/2phase study to evaluate the pharmacokinetics, safety, tolerability, immunogenicity, and pharmacodynamics of albuferon™ in the treatment experienced subjects with chronic hepatitis C

✍ Scribed by V. Balan; M. Sulkowski; D. Nelson; G. Everson; T. Bambury; J. Recta; J. Zhong; H. Mesghali; J. Murray; B. Osborn; L. Novello; W. Freimuth; G. Subramanian

Book ID: 119530222
Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 126 KB
Volume: 38
Category: Article
ISSN: 0270-9139
DOI: 10.1016/s0270-9139(03)80356-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

456 Safety, pharmacokinetics and pharmac

456 Safety, pharmacokinetics and pharmacodynamic results of higher doses of albuferon in a phase 12 single and double dose-escalation study in treatment experienced subjects with chronic hepatitis C

✍ V. Balan; M. Sulkowski; D. Nelson; G. Everson; R. Dickson; L. Lambiase; A. Post; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 63 KB

18 A phase 2 study to assess antiviral r

18 A phase 2 study to assess antiviral response, safety, and pharmacokinetics of albuferon™ in IFN-α NA1VE subjects with genotype 1 chronic hepatitis C

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 135 KB

A Phase 1, dose escalation study to eval

A Phase 1, dose escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple oral daily doses of ELND006 in healthy elderly subjects

✍ Liang, Earvin; Liu, Wenzhong Jerry; Lohr, Lisa; Nguyen, Van; Lin, Holly; Munson, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB

W1011 Phase I Study to Evaluate the Safe

W1011 Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Silymarin (SM) Following Chronic Dosing in Patients with Chronic Hepatitis C (HCV)

✍ Schrieber, Sarah J.; Soule, Tedi A.; Wen, Zhiming; Wahed, Abdus S.; Smith, Phili 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 132 KB

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND,

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE ESCALATING ORAL DOSES OF GS-9620 IN HEALTHY SUBJECTS

✍ U. Lopatin; G. Wolfgang; R. Kimberlin; D. Turnas; M. Cornprost; G. Chittick; C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

A phase 2 study to evaluate the antivira

A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients

✍ Vincent G. Bain; Kelly D. Kaita; Eric M. Yoshida; Mark G. Swain; E. Jenny Heathc 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 198 KB